Angstrom Pharmaceuticals angstrominc.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1148)

Angstrom Pharmaceuticals, a privately held pharmaceutical company headquartered in San Diego, California, is developing a new class of proprietary drugs that treat diseases involving cell migration, invasion, and metastasis. Angstrom's lead product, A6 peptide, is a First-in-Class "Oncoparalytic", stopping tumors from metastasizing by paralyzing cancer cells.

Angstrom Pharmaceuticals, a privately held pharmaceutical company headquartered in San Diego, California, is developing a new class of proprietary drugs that treat diseases involving cell migration, invasion, and metastasis. Angstrom's lead product, ...Show all

Company (Alive / Active)

Phone: 858-314-2356

Fax: 858-314-2355

990 Highland Drive
Suite 314
Solana Beach, 92075
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Angstrom Pharmaceuticals $10.3M Aug 1, 2013
See all 26 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Angstrom Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 26 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Modulation of intracellular signaling Mar 04, 2011 Apr 15, 2014 Patent
Compositions and methods for modulation of cell migration Mar 05, 2010 Nov 20, 2012 Patent
Anti-invasive and anti-angiogenic compositions Aug 30, 2010 Feb 07, 2012 Patent
Anti-invasive and anti-angiogenic compositions Nov 15, 2006 Oct 05, 2010 Patent